Welchol

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Welchol

Quick Facts

Property Description
Active ingredient Colesevelam Hydrochloride
Form Tablet, Powder for oral suspension
Pharmacological class Bile Acid Sequestrant (BAS)
General purpose Lowering LDL cholesterol
Origin Synthetic polymer

What is Colesevelam Hydrochloride and What Class Does It Belong To?

Welchol is the trade name for this prescription medication, containing the active ingredient Colesevelam Hydrochloride. This drug is classified as a Bile Acid Sequestrant (BAS), also known more broadly as an antihyperlipidemic agent. This class of agents is primarily employed in the management of high blood cholesterol levels. This classification confirms the medicine's core function is related to managing circulating fats in the body.

Colesevelam Hydrochloride is considered a newer generation BAS, clinically recognized for its favorable gastrointestinal tolerability compared to older agents in the class. As an orally administered medicine, its function is based on physically binding substances in the gastrointestinal tract rather than being absorbed into the body, a key distinguishing feature from systemic therapies. This classification defines its unique role as a non-systemic intervention in lipid and metabolic health.


Synthetic Composition and Available Forms of Welchol

The active ingredient, Colesevelam, is a synthetic polymer that is specifically designed to be non-absorbable by the body. This medication is available for oral administration in two primary dosage forms: a convenient tablet and a powder for oral suspension. This two-form availability allows physicians to tailor administration to the needs of different patient groups, including pediatric patients (10 to 17 years) where the powder form may be preferred.


General Purpose: How Does This Drug Help Manage Cholesterol?

The general purpose of this medicine is to help manage high levels of cholesterol, primarily by lowering low-density lipoprotein cholesterol (LDL-C). The drug achieves this by interfering with the natural process of bile acid recycling in the intestines. Bile acid sequestrants reduce LDL cholesterol by binding bile acids in the gut. This mechanism provides a way the medicine reduces the amount of "bad" cholesterol in the blood.

Colesevelam works by binding to bile acids, forcing their elimination. The liver then compensates by pulling more cholesterol out of the bloodstream to manufacture replacement bile acids, resulting in a reduction of the overall circulating LDL-C. This action provides an established, non-systemic method to support cardiovascular health and is also clinically used as an adjunct in managing aspects of type 2 diabetes mellitus.

Regulatory References

  1. NIH

What side effects are possible with Welchol?

Possible Side Effects and Safety Information

The safety profile of Colesevelam Hydrochloride (Welchol) is primarily characterized by effects within the digestive system, consistent with its classification as a non-absorbed Bile Acid Sequestrant, as documented in official regulatory labeling.


Adverse Reaction Classification

Adverse reactions are predominantly classified as Common in regulatory documents, meaning they occur in a specified percentage of patients in clinical trials. These effects are mainly related to Gastrointestinal Disorders.

Category Examples (Common)
Gastrointestinal Disorders Constipation, Dyspepsia, Nausea, Flatulence, Abdominal pain
Other System Disorders Headache, Myalgia, Pharyngitis

Serious Safety Concerns and Restrictions

Official labeling highlights the risks associated with the drug's action and metabolic consequences:

  • Serious Adverse Reactions: High-level safety warnings address the potential for Gastrointestinal Obstruction (including bowel and esophageal obstruction) and the risk of Acute Pancreatitis in patients experiencing marked increases in serum Triglyceride (TG) concentrations.

  • Contraindications: Use is strictly contraindicated in individuals with a history of bowel obstruction or with very high baseline serum TG concentrations (e.g., greater than 500 mg/dL). Use is also generally not recommended in patients with severe gastrointestinal motility disorders.

  • Fat-Soluble Vitamin Absorption: The drug's mechanism can interfere with the absorption of certain co-administered substances, including fat-soluble vitamins (Vitamins A, D, E, and K), which is an explicitly documented safety consequence.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose information for Welchol (colesevelam) is limited, as the drug is a non-absorbed polymer. Excessive doses are not expected to cause systemic toxicity but may lead to more severe local gastrointestinal effects, such as increased constipation.

Required Emergency Actions

The primary serious risk associated with this drug relates to its potential to elevate serum triglyceride (TG) levels, which can lead to a condition known as acute pancreatitis. The manufacturer and regulatory documents strictly advise the following:

  • Seek prompt medical attention if symptoms of acute pancreatitis occur. These symptoms may include severe abdominal pain, with or without nausea and vomiting.
  • Discontinue Welchol immediately if you experience these symptoms or if lipid monitoring reveals a serum TG concentration greater than 500 mg/dL.

High-Risk Conditions

Welchol is not recommended for use in patients with a history of bowel obstruction or severe gastrointestinal motility disorders (such as gastroparesis), as the non-absorbed nature of the product could potentially worsen these conditions. Additionally, use is strictly contraindicated in individuals with serum TG concentrations over 500 mg/dL or a history of hypertriglyceridemia-induced pancreatitis.

Therapeutic Uses of Welchol

What Welchol Treats: Main Uses and Benefits

The primary therapeutic role of Colesevelam Hydrochloride is relevant for providing supportive benefit in two distinct, chronic metabolic domains, generally helping to manage key cardiovascular risk factors and assists with maintaining metabolic stability.

This medication is commonly used to address symptoms related to systemic imbalance, specifically persistently high levels of Low-Density Lipoprotein Cholesterol (LDL-C). It is applied in addressing conditions involving episodic or fluctuating manifestations of high cholesterol in adults, and is also relevant for managing this symptom cluster in adolescents (ages 10 to 17) with the genetic condition Heterozygous Familial Hypercholesterolemia (HeFH).

The primary therapeutic role is used for managing elevated LDL-C, while also playing a role in managing glycemic control for adult patients with Type 2 Diabetes Mellitus. This supportive use contributes to easing the overall symptom load related to elevated lipids and may assist with maintaining functional stability.


Quick Fact: Relief for Metabolic Symptoms
Primary Domain Lipid Management (addressing high LDL-C)
Secondary Domain Glycemic Control (in Type 2 Diabetes Mellitus)
Usage Context Adjunctive Therapy (used as an add-on to other established treatments)
Patient Benefit Provides support that helps ease the overall symptom burden by assisting with metabolic stability

Regulatory References

  1. NIH DailyMed Drug Labeling

Eligibility and Restrictions for Use

Welchol (colesevelam) is a medication used to reduce LDL-cholesterol in adults and certain pediatric patients, and to improve glycemic control in adults with type 2 diabetes mellitus.

Approved Patient Populations

  • Adults with primary hyperlipidemia or type 2 diabetes mellitus.
  • Pediatric patients (boys and postmenarchal girls, 10 to 17 years of age) with heterozygous familial hypercholesterolemia, often in combination with a statin.

Contraindications (Who Should NOT Use Welchol)

Welchol is contraindicated in patients with a history of:

  • Bowel obstruction.
  • Serum triglyceride (TG) concentrations >500 mg/dL.
  • Pancreatitis caused by high triglyceride levels.

It should not be used for treating type 1 diabetes or diabetic ketoacidosis. Due to its constipating effects and potential for interaction, caution is advised in patients with pre-existing gastrointestinal motility disorders like gastroparesis, or those who have recently had major gastrointestinal surgery. The oral suspension contains phenylalanine and should be used with caution in individuals with phenylketonuria (PKU). Welchol has not been studied in children under 10 years of age or in girls before their first menstrual period.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Colesevelam Hydrochloride (Welchol) is primarily defined by its non-absorbed nature, which causes a pharmacokinetic interaction through reduced gastrointestinal absorption of co-administered substances. This binding action mandates specific constraints documented in regulatory labeling.

Documented Pharmacokinetic and Pharmacodynamic Interactions

Category Interacting Entity Regulatory Outcome / Restriction
Exposure-Decreasing Cyclosporine, Levothyroxine, Olmesartan Medoxomil, Phenytoin, Sulfonylureas, Oral Contraceptives Reduction in systemic exposure / plasma levels.
Exposure-Increasing Metformin Extended Release (ER) Documented increase in plasma exposure.
Pharmacodynamic Warfarin Potential for reduced International Normalized Ratio (INR) due to interference with Vitamin K absorption.

Administration-Timing and Substance Restrictions

Official regulatory information requires that many interacting medicinal products, including Levothyroxine and Sulfonylureas, must be administered at least 4 hours prior to Colesevelam Hydrochloride to prevent a clinically significant reduction in their absorption. This timing rule also applies to fat-soluble vitamin supplements (A, D, E, K). Specific populations, such as patients on Warfarin or those with malabsorption syndromes, are noted for increased susceptibility to interaction-related risks, specifically concerning Vitamin K and fat-soluble vitamin deficiencies.

Mechanism of Action

How Welchol Works: Mechanism of Action

Bile Acid Sequestration and Enterohepatic Interruption

This domain describes the primary action of colesevelam as a non-absorbable polymer acting in the intestine, where it physically binds to and sequesters bile acids. This mechanistic interaction interrupts the normal enterohepatic circulation of bile acids, resulting in the complex being excreted.

Compensatory Hepatic Cholesterol Homeostasis

The depletion of the bile acid pool forces the liver to synthesize replacement bile acids from cholesterol, thereby upregulating the expression of LDL receptors on the liver cell surface. This systemic feedback mechanism results in the accelerated clearance of LDL particles from the bloodstream, causing the reduction of circulating LDL-C concentrations.

Secondary Glucose Metabolism Modulation

A secondary mechanistic domain involves the drug's action in the gastrointestinal tract to modulate glucose absorption and potentially affect intestinal hormone signaling. This process, independent of the cholesterol effect, results in a measurable reduction of systemic glucose concentrations.

Dosage and Administration Information

Official Administration Guidelines for Welchol

Welchol (colesevelam hydrochloride) is a medication for oral administration available in two primary forms: a 625 mg film-coated tablet and a powder for oral suspension (available in 3.75 gram and 1.875 gram packets). The entire administration process is strictly non-systemic, occurring within the gastrointestinal tract.


Standard Labeled Dosing and Timing

Category Adult Regimen (3.75 grams total daily dose) Administration Conditions
Tablet 6 tablets once daily, or 3 tablets twice daily Swallowed whole with a meal and liquid.
Powder One 3.75 g packet once daily, or One 1.875 g packet twice daily Taken with a meal; never taken in dry form.

For adults, the total daily dose is 3.75 grams, administered either once daily or in two divided doses. The tablets must be swallowed whole and should not be crushed or broken. The powder for oral suspension must be mixed with 4 to 8 ounces of water, fruit juice, or a diet soft drink before ingestion.


Special Procedural Instructions

Population/Condition Official Instruction
Pediatric (10–17 yrs) Recommended dose is 3.75 grams daily. The oral suspension form is recommended due to tablet size.
Concomitant Drugs Administer other drugs that may interact, especially those with narrow therapeutic indices, at least 4 hours prior to taking colesevelam.
Missed Dose If a dose is missed, take it with a later meal or skip it and continue the regular schedule; do not take a double dose to compensate.

Treatment is part of a long-term plan, and it is generally recommended to monitor lipid levels within 4 to 6 weeks after the start of therapy to assess initial response.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Welchol

Evidence for use in Primary High Cholesterol

Welchol was studied for its association with outcomes when used alongside diet and exercise in adults with primary high cholesterol. These studies were generally organized as randomized controlled trials, where participants were assigned by chance to receive either the medicine or a placebo (an inactive substance) to see if changes are measured during the study period.

Studies explored the impact of the medicine on various measures of cholesterol. Findings indicate that, for this population, Welchol was observed in studies to be associated with changes in levels of low-density lipoprotein cholesterol (LDL-C). Research has explored these patterns of change in the observed populations.

It is important to note that these studies monitored outcomes related to systemic or functional imbalance, focusing primarily on short-term changes. Results apply only to the populations studied, and long-term effects on clinical outcomes are not fully established.


Evidence for use in Type 2 Diabetes Mellitus

Welchol was also evaluated in adults with Type 2 Diabetes Mellitus as an add-on to diet and exercise in research examining blood sugar outcomes. This research relied on studies that compared the medicine to a placebo, focusing on changes in the level of A1C, a measure of average blood sugar over time. Studies reported how this outcome evolved in the observed populations.

Findings suggest that for the group of adults studied, Welchol, when added to other therapies, was evaluated for its association with a measured change in blood sugar outcomes reflecting systemic or functional imbalance. Follow-up durations were limited in these studies, and comparative evidence against other treatments is limited. Research is ongoing to fully understand how this medicine was observed in the broader evidence landscape.


Evidence for use in Pediatric High Cholesterol

Research examined the use of Welchol specifically in a group of children and adolescents (boys and postmenarchal girls, aged 10 to 17) diagnosed with heterozygous familial hypercholesterolemia (HeFH). Studies exploring this setting observed patterns of changes in LDL-C levels measured during the study period. Data for certain groups remain insufficient, and long-term effects are not fully established for this younger population.


What is Still Uncertain About Welchol

Research provides insight into short-term changes, but several areas need more evidence. Long-term effects on cardiovascular events (like heart attack or stroke) are not fully established for Welchol. Findings were mixed when research examined the impact on triglyceride levels, another type of fat in the blood. Research has described patterns where Welchol was associated with increases in triglycerides in some populations, indicating an area where more research is needed. The research does not determine whether an individual's personal measured changes will align with the group patterns observed in the studies.

Frequently Asked Questions (FAQ)

Common questions about Welchol (FAQ)


Q: What is the primary reason Welchol is prescribed by doctors?

Official regulatory documents indicate that the medicine is approved as an adjunct to diet and exercise to reduce elevated low-density lipoprotein cholesterol (LDL-C) in adults with primary hyperlipidemia. It is also approved to help improve blood sugar control in adults with Type 2 Diabetes Mellitus.

Q: Is Welchol considered a statin drug?

No, Welchol is officially classified as a bile acid sequestrant—a completely different class of medication. Regulatory information indicates its use alone or in combination with a statin, which reflects that it is from a different class of medicine.

Q: How does Welchol differ from other medications used for cholesterol?

It is a non-absorbed polymer that acts within the intestine to bind bile acids, preventing them from being recycled by the body. This action results in the liver synthesizing replacement bile acids from cholesterol, which is associated with a reduction of circulating LDL-C concentrations. This mechanism is distinct from statins, which reduce cholesterol production inside the liver.

Q: What are the most common side effects reported by patients taking Welchol?

In clinical trials, the most commonly reported side effects (occurring in two percent or more of patients) were related to the digestive tract, including constipation, indigestion (dyspepsia), and nausea.

Q: Does Welchol cause problems with digestion or stomach issues?

Yes, issues such as constipation and indigestion (dyspepsia) are frequently reported, as the medicine acts solely within the gastrointestinal tract. The product label also contains precautions regarding the risk of gastrointestinal obstruction due to the constipating effects.

Q: Is it common to experience constipation when starting Welchol?

Yes, official product information indicates that constipation is among the most common adverse reactions reported in clinical trials, occurring more often in patients taking this medicine than in those taking a placebo.

Q: Why do some people experience gas or bloating with Welchol?

Gastrointestinal symptoms such as dyspepsia (indigestion), which can include gas, bloating, or stomach discomfort, are among the most common adverse reactions reported in clinical trials due to the medicine's non-absorbed action in the digestive tract.

Q: Why does Welchol sometimes cause an increase in triglycerides?

Official regulatory labeling notes that this medicine, similar to other bile acid sequestrants, can increase serum triglyceride (TG) concentrations in some patients. Due to the potential for high triglycerides to cause acute pancreatitis, monitoring of triglyceride levels is noted in regulatory documents as a necessary precaution.

Q: Is Welchol known to cause muscle pain or weakness?

In clinical trials, muscle pain and weakness were reported as less common side effects, occurring in less than four percent of treated patients.

Q: Does Welchol cause headaches?

Headache was reported as a side effect in clinical trials, but regulatory information categorized it as a less common occurrence.

Q: Is it possible to be allergic to Welchol?

Yes, regulatory documents note that the medicine is contraindicated (should not be used) in patients who have a known hypersensitivity reaction to the active substance or any of its components. Allergic reactions, including hypersensitivity, have been reported.

Q: What should be done if a person has a bad reaction to Welchol?

Official regulatory documents note that the medicine should be discontinued and prompt medical attention should be sought if a person experiences symptoms of a serious complication. This includes symptoms such as severe abdominal pain (with or without vomiting), or signs of severe constipation.

Q: How long does it usually take to see changes after starting Welchol?

Regulatory guidelines recommend that lipid parameters, including cholesterol and triglyceride levels, should be monitored by a healthcare provider within 4 to 6 weeks after starting the medicine to assess the initial response to therapy.

Q: Can Welchol be taken at the same time as other heart medications?

Due to the potential for reduced absorption of other medicines, regulatory labeling requires that many interacting medicinal products, especially those with narrow therapeutic indices, are required by regulatory labeling to be administered at least 4 hours prior to this medicine. This precaution is general and applies to many co-administered medications.

Q: Does the time of day matter when taking Welchol?

Official regulatory documents state that the medicine must be taken with a meal and that the total daily dose can be given either once daily or in two divided doses. The specific time of day (morning or evening) is generally determined by the meal schedule and the patient's prescribed dosing regimen (once or twice daily).

Q: Is Welchol typically started at a low dose?

The official labeling provides a single recommended daily dosage for adults, whether used alone or with a statin. It does not describe a lower starting dose that requires titration up to this recommended dose. The labeling provides a recommended daily dosage for both the tablet and powder forms.

Q: Does taking Welchol require regular blood tests?

Official labeling notes that lipid parameters, including triglyceride levels, are generally obtained before starting the medicine and monitored periodically thereafter as a necessary step.

Q: Do studies suggest Welchol can be used alongside statins?

Yes, official regulatory indications include its use as an adjunct to diet and exercise to lower elevated LDL-C levels, and it may be used either alone (monotherapy) or in combination with a statin.

Q: Is Welchol prescribed for people who do not tolerate statin drugs well?

The medicine is officially approved for use as monotherapy (alone) to reduce high cholesterol in adults. Monotherapy can be used in situations where individuals may not tolerate or adequately respond to other medicines, such as statins.

Q: Is Welchol a medication that cures high cholesterol?

The medicine is officially indicated as an adjunct to diet and exercise to reduce elevated LDL-C and improve blood sugar control. It is generally understood to be a treatment for management, not a cure, for chronic conditions like hyperlipidemia and Type 2 Diabetes.

Q: If a person feels fine, should they still continue to take Welchol?

The medicine is prescribed for chronic conditions, such as high cholesterol, that often do not have noticeable symptoms. The medicine is intended as part of a long-term treatment plan that should be followed as prescribed, and continuation of the regimen is generally determined by a healthcare provider.

Q: Are there specific medical conditions that mean a person should not use Welchol?

Official regulatory documents state that the medicine is contraindicated (should not be used) in patients with a history of bowel obstruction, serum triglyceride levels greater than 500 , mg/dL, or a history of pancreatitis caused by high triglycerides.

Q: Can older adults safely use Welchol?

Clinical trials included patients up to 86 years of age. Regulatory review indicates no evidence for special considerations when the medicine is administered to older patients compared to younger adult patients.

Q: Is Welchol safe for people who have a history of liver problems?

Official regulatory documents note that the medicine is not absorbed systemically by the body. Therefore, the fact that it is not absorbed systemically is noted in regulatory information, but the medicine is contraindicated in patients with very high triglycerides, which can potentially affect the liver and pancreas.

Q: What is known about Welchol's use in people with kidney disease?

Official regulatory labeling states that the medicine is not systemically absorbed and is not metabolized by the body's major organs, including the kidneys. Therefore, no specific dose adjustments are required for patients with impaired kidney function.

Q: Is Welchol a lifetime medication?

The medicine is generally intended as part of a long-term treatment plan for managing chronic conditions like high cholesterol. While official labeling notes that the long-term effect on cardiovascular outcomes has not been fully established, continuation of the regimen is generally determined by a healthcare provider.

Q: What should be done if a person has a bad reaction to Welchol?

Official regulatory documents note that the medicine should be discontinued and prompt medical attention should be sought if a person experiences symptoms of a serious complication. This includes symptoms such as severe abdominal pain (with or without vomiting), or signs of severe constipation.

Q: Does Welchol have any restrictions regarding driving or operating machinery?

The official label does not include a specific general warning against driving. However, because adverse reactions reported in clinical trials include dizziness and fatigue (less common effects), a person's response to the medicine should be considered as these may affect alertness.

Q: Can Welchol be used during pregnancy or while breastfeeding?

According to official labeling, this medicine is not absorbed systemically by the body. It is designated as Pregnancy Category B. However, studies in pregnant women have not been conducted, and it is not known if the medicine is excreted into human milk during breastfeeding.

How should Welchol be stored and disposed of?

Official Storage and Disposal Requirements

Welchol (colesevelam) must be stored strictly according to its official labeled requirements to ensure stability and effectiveness.

Storage Component Official Requirement
Temperature Store at 25 C (77 F). Permitted excursions between 15 C and 30 C.
Protection Protect from moisture; keep container tightly closed and away from excess heat. Do not freeze.
Stability After first opening the bottle of tablets, the medicine must be discarded after 60 days.
Child Safety Keep out of the reach and sight of children. The product is supplied with a child-resistant cap.
Disposal Dispose of unused or expired Welchol according to local requirements, which may involve consultation with a healthcare professional or a drug take-back program. Do not flush medications down the toilet or pour them down a drain unless officially instructed to do so.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Welchol found in:

A-Z Index: